Show
Sort by
-
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
-
- Journal Article
- A1
- open access
Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients
-
Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib
-
Identification of a predictive signature based on immunohistochemical (IHC), RNA-seq and epigenetic profiling of melanoma metastases for response to ipilimumab-based immunotherapy
-
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
-
Priming of cytotoxic T lymphocyte responses by dendritic cells: induction of potent anti-tumor immune responses